441 related articles for article (PubMed ID: 8586531)
1. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
[TBL] [Abstract][Full Text] [Related]
2. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype.
Sobotta D; Sominskaya I; Jansons J; Meisel H; Schmitt S; Heermann KH; Kaluza G; Pumpens P; Gerlich WH
J Gen Virol; 2000 Feb; 81(Pt 2):369-78. PubMed ID: 10644835
[TBL] [Abstract][Full Text] [Related]
3. Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope.
Park JH; Lee MK; Kim HS; Kim KL; Cho EW
J Viral Hepat; 2003 Jan; 10(1):70-9. PubMed ID: 12558915
[TBL] [Abstract][Full Text] [Related]
4. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K
Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
[TBL] [Abstract][Full Text] [Related]
6. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
7. Tetrapeptide QDPR is a minimal immunodominant epitope within the preS2 domain of hepatitis B virus.
Sominskaya I; Bichko V; Pushko P; Dreimane A; Snikere D; Pumpens P
Immunol Lett; 1992 Jul; 33(2):169-72. PubMed ID: 1446923
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
10. Fine-mapping of the B-cell epitope domain at the N-terminus of the preS2 region of the hepatitis B surface antigen.
Sominskaya I; Paulij W; Jansons J; Sobotta D; Dreilina D; Sunnen C; Meisel H; Gerlich WH; Pumpens P
J Immunol Methods; 2002 Feb; 260(1-2):251-61. PubMed ID: 11792393
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of preS2 of the hepatitis B virus surface antigen against a conformation-dependent monoclonal antibody using synthetic peptides.
Lee MK; Kim KL; Hahm KS
Biochem Mol Biol Int; 1996 Dec; 40(6):1077-85. PubMed ID: 8988319
[TBL] [Abstract][Full Text] [Related]
12. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E
Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of a dominant B-cell epitope from the preS2 region of hepatitis B virus in the form of an inserted peptide segment in maltodextrin-binding protein.
Saul FA; Vulliez-le Normand B; Lema F; Bentley GA
J Mol Biol; 1998 Jul; 280(2):185-92. PubMed ID: 9654443
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
Fei GZ; Sylvan SP; Hellström UB; Yao GB
J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
[TBL] [Abstract][Full Text] [Related]
16. Antigenic mapping of the surface proteins of infectious hepatitis B virus particles.
Petit MA; Capel F; Riottot MM; Dauguet C; Pillot J
J Gen Virol; 1987 Nov; 68 ( Pt 11)():2759-67. PubMed ID: 2445903
[TBL] [Abstract][Full Text] [Related]
17. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product.
Usuda S; Okamoto H; Iwanari H; Baba K; Tsuda F; Miyakawa Y; Mayumi M
J Virol Methods; 1999 Jun; 80(1):97-112. PubMed ID: 10403681
[TBL] [Abstract][Full Text] [Related]
18. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library.
Chen YC; Delbrook K; Dealwis C; Mimms L; Mushahwar IK; Mandecki W
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1997-2001. PubMed ID: 8700874
[TBL] [Abstract][Full Text] [Related]
19. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
[TBL] [Abstract][Full Text] [Related]
20. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
